单孔胸腔镜在非小细胞肺癌治疗中的应用价值

Value of uniport video-assisted thoracoscopic surgery in the treatment of non-small cell lung cancer

目的:研究单孔胸腔镜(uniport video-assisted thoracoscopic surgery,Uni-VATS)对治疗非小细胞肺癌(non-small cell lung cancer,NSCLC)的临床应用价值。方法:前瞻性研究2017年7月至2018年6月四川省科学城医院胸外科接受Uni-VATS和多孔胸腔镜(multiport v ideo-assisted thoracoscopicsurgery,Mul-VATS)治疗的200例NSCLC患者,比较其术后发生并发症的差异。结果:Uni-VATS组的手术时间、出血量与Mul-VATS组比较,差异无统计学意义(均P>0.05),Uni-VATS组术后疼痛评分、带管时间、各种并发症的发生均较Mul-VATS组低(均P<0.05)。结论:Uni-VATS与Mul-VATS一样安全可靠,其在术后疼痛管理和并发症的控制上更具优势,能提高患者的生活质量,具有临床应用价值。

Objective: To study the clinical application value of uniport video-assisted thoracoscopic surgery (Uni-VATS) in the treatment of non-small cell lung cancer (NSCLC). Methods: A prospective study was conducted on 200 patients with NSCLC who received Uni-VATS and multiport video-assisted thoracoscopic surgery (Mul- VATS) in thoracic surgery department of Sichuan Science City Hospital from July 2017 to June 2018, and the differences in postoperative complications were compared. Results: There were no statistically significant differences in operative time and blood loss between the two groups (both P>0.05), and the postoperative pain score, chest-drain duration time and the occurrence of various complications in the Uni-VATS group were lower than those in the Mul-VATS group (all P<0.05). Conclusion: Uni-VATS is as safe and reliable as Mul-VATS, and it has obvious advantages in postoperative pain management and complication control. It can improve the quality of life of patients and has clinical application value.